MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Malignant Glioma

(UMLS:C0555198)

UMLS ID:: C0555198
MeSH ID:: D005910

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.465.625.600.380|C04.557.470.670.380|C04.557.580.625.600.380

Synonym(s)

Malignant Glioma

GLIOMA, MALIGNANT

Glioma (except Nasal glioma, not neoplastic)

Glioma, NOS (except Nasal glioma, not neoplastic)

Glioma, malignant

Glioma, malignant, no ICD-O subtype

High Grade Glioma

High-Grade Glioma

Malignant Glial Neoplasm

10.

Malignant Glial Tumor

11.

Malignant Neuroglial Neoplasm

12.

Malignant Neuroglial Tumor

13.

Malignant glioma

14.

Malignant glioma - category

15.

malignant glioma

Associated Drug(s)

	Name	Number of Reports	Data Source
1	Temozolomide	FAERS: 5	OFFSIDES US FAERS
2	Carmustine	FAERS: 2	US FAERS
3	Dimethyl Fumarate	FAERS: 2	US FAERS
4	Clozapine	FAERS: 1	US FAERS
5	Methotrexate	FAERS: 1	US FAERS
6	Tenofovir	FAERS: 1	US FAERS
7	pasireotide	FAERS: 1	US FAERS
8	Clobazam		OFFSIDES
9	Cortisone		OFFSIDES
10	Cytarabine		OFFSIDES
11	Daunorubicin		OFFSIDES
12	Mercaptopurine		OFFSIDES
13	Procarbazine		OFFSIDES
14	Thioguanine		OFFSIDES
15	propiomazine		OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	Ganglioneuroma	61.7%
2	Craniopharyngioma	42.3%
3	Neuroectodermal Tumor, Melanotic	42.3%
4	Neuroendocrine Tumors	42.3%
5	Retinoblastoma	39.4%
6	Neuroblastoma	38.3%
7	Medulloblastoma	37%
8	melanoma	36.9%
9	Adenoma, Acidophil	36.2%
10	leukemia	34.4%
11	Ganglioneuroblastoma	34.4%
12	Carcinoid Tumor	32.6%
13	Neurilemmoma	31.6%
14	Basal cell carcinoma	29.5%
15	Carcinoma, Papillary	29.5%
16	Squamous cell carcinoma	29.5%
17	Cystadenoma	29.5%
18	Mesothelioma	29.5%
19	Carcinoma, Basal Cell	29.5%
20	Adenoma	29%
21	Carcinoma	29%
22	Epithelioma	29%
23	Paraganglioma	28.7%
24	Meningioma	28.4%
25	Histiocytic Disorders, Malignant	27.6%
26	Chordoma	27.4%
27	Teratoma	27.4%
28	Germinoma	27.4%
29	Teratocarcinoma	27.4%
30	Trophoblastic Neoplasms	26.4%
31	Hutchinson's Melanotic Freckle	26.3%
32	Melanoma, Amelanotic	26.3%
33	Melanoma, Experimental	25.7%
34	Cystadenocarcinoma	25.2%
35	Mucoepidermoid Carcinoma	25.2%
36	Malignant Carcinoid Syndrome	25.2%
37	Carcinosarcoma	25.2%
38	Hemangiosarcoma	25.2%
39	lymphangiosarcoma	25.2%
40	Carcinoma, Ehrlich Tumor	24.2%
41	Carcinoma, Lewis Lung	24.2%
42	Neoplasms, Germ Cell and Embryonal	23.4%
43	Germ Cell Cancer	23.4%
44	Lymphoma	23.1%
45	Dermoid Cyst	22.9%
46	Composite Lymphoma	22.2%
47	Neoplasms, Glandular and Epithelial	22.1%
48	Hamartoma	22%
49	Neoplasms, Hormone-Dependent	22%
50	Neoplasms, Multiple Primary	22%
51	Paraneoplastic Syndromes	22%
52	Precancerous Conditions	22%
53	Neoplasms, Second Primary	22%
54	Pheochromocytoma	21.9%
55	Carcinoma, Lobular	21.8%
56	Neuroectodermal Tumors	21.4%
57	Carcinoma 256, Walker	21.4%
58	Bowen's Disease	21%
59	Leukemia, Plasma Cell	21%
60	Choriocarcinoma	20.9%
61	Leukemia, Experimental	20.8%
62	Acanthoma	20%
63	Adenofibroma	19.9%
64	Fibroadenoma	19.9%
65	Ameloblastoma	19.4%
66	Angiokeratoma	19.4%
67	Hemangioma	19.4%
68	hemangiopericytoma	19.4%
69	Lymphangioma	19.4%
70	Mesenchymoma	19.4%
71	Nevus	19.4%
72	Hepatoblastoma	19.4%
73	Mixed Tumor, Mullerian	19.4%
74	Neoplasms, Neuroepithelial	19.4%
75	Angiofibroma	19.4%
76	Gliomatosis cerebri	19.4%
77	Sarcoma	19.4%
78	Chondrosarcoma	19.2%
79	leiomyosarcoma	19.2%
80	liposarcoma	19.2%
81	synovial sarcoma	19.2%
82	Angiomyolipoma	19.2%
83	Clear Cell Sarcoma of Soft Tissue	19.2%
84	Alveolar Soft Part Sarcoma	19.2%
85	Sarcoma, Myeloid	19.2%
86	Carcinoid Heart Disease	18.8%
87	Adenocarcinoma	18.4%
88	Carcinoma in Situ	18.4%
89	Carcinoma, Transitional Cell	18.4%
90	Papilloma	18.4%
91	Pseudomyxoma Peritonei	18.4%
92	Papillomatosis	18.4%
93	Adenomatosis, Pulmonary	18.4%
94	Adenomatous Polyps	18.4%
95	Carcinoma, Large Cell	18.4%
96	Carcinoma, Small Cell	18.4%
97	Leukemia, Radiation-Induced	18%
98	Cyst	17.8%
99	Neoplastic Processes	17.8%
100	Neoplastic Syndromes, Hereditary	17.8%
101	Pregnancy Complications, Neoplastic	17.8%
102	Neoplasms, Experimental	17.6%
103	Dysgerminoma	16.8%
104	Neuroma	16.8%
105	Seminoma	16.8%
106	Fibrosarcoma	16.3%
107	Osteosarcoma	16.3%
108	Sarcoma, Experimental	15.8%
109	Endometrial Stromal Sarcoma	15.7%
110	Thymoma	15.7%
111	Plasmacytoma	15.6%
112	Malignant histiocytosis	15.5%
113	Histiocytic sarcoma	15.5%
114	Multiple Endocrine Neoplasia	15.1%
115	Leukemia L1210	14.8%
116	Leukemia P388	14.8%
117	Malignant Fibrous Histiocytoma	14.8%
118	Neoplasms, Radiation-Induced	14.7%
119	Acoustic Neuroma	14.6%
120	Lymphangioleiomyomatosis	13.8%
121	Basal Cell Nevus Syndrome	13.7%
122	Rhabdomyosarcoma	13.4%
123	Giant Cell Tumor of Bone	13.4%
124	Neurofibrosarcoma	13.2%
125	Adenoid Cystic Carcinoma	13.1%
126	Adenocarcinoma, Clear Cell	13.1%
127	Cholangiocarcinoma	13.1%
128	Cervical Intraepithelial Neoplasia	13.1%
129	Hepatocellular Adenoma	13%
130	Hodgkin Disease	12.9%
131	Lymphoma, Non-Hodgkin	12.9%
132	Carcinoma, Pancreatic Ductal	12.9%
133	Glioma	12.8%
134	Malignant Glioma	12.8%
135	Nephroblastoma	12.3%
136	Paraneoplastic Encephalomyelitis	12.2%
137	Mammary Neoplasms, Experimental	12%
138	Phyllodes Tumor	12%
139	Hemangioendothelioma	12%
140	Lipoma	12%
141	Myoma	12%
142	Myxoma	12%
143	Angiolipoma	12%
144	Myelolipoma	12%
145	Neoplasms, Bone Tissue	12%
146	Neoplasms, Fibrous Tissue	12%
147	Smooth Muscle Tumor	12%
148	Desmoplastic Small Round Cell Tumor	12%
149	Chondroma	12%
150	Enchondroma	12%
151	Vipoma	12%
152	Dermatofibrosarcoma	11.9%
153	Dermatofibrosarcoma Protuberans	11.9%
154	Sarcoma 180	11.9%
155	Tuberous Sclerosis	11.7%
156	Abdominal Neoplasms	11.5%
157	Erythroplasia	11.5%
158	Follicular cyst	11.5%
159	Head and Neck Neoplasms	11.5%
160	Mucocele	11.5%
161	Pilonidal Cyst	11.5%
162	Soft Tissue Neoplasms	11.5%
163	Thoracic Neoplasms	11.5%
164	Thyroglossal Cyst	11.5%
165	Synovial Cyst	11.5%
166	Aberrant Crypt Foci	11.5%
167	Prolactinoma	11.3%
168	Growth Hormone-Secreting Pituitary Adenoma	11.3%
169	Lymphomatoid Granulomatosis	11.3%
170	neurofibroma	11.2%
171	Primary amyloidosis	11.2%
172	Klatskin Tumor	10.5%
173	Alveolar rhabdomyosarcoma	10.5%
174	Hydatidiform Mole	10.4%
175	Carcinoma, Ovarian Epithelial	10%
176	Mesoblastic Nephroma	9.8%
177	Leukemia, Myelomonocytic, Chronic	9.6%
178	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.6%
179	Digestive System Neoplasms	9.6%
180	Endocrine Gland Neoplasms	9.6%
181	Eye Neoplasms	9.6%
182	Nervous System Neoplasms	9.6%
183	Astrocytoma	9.5%
184	Ependymoma	9.5%
185	oligodendroglioma	9.5%
186	Ganglioglioma	9.5%
187	gliosarcoma	9.5%
188	Anaplastic astrocytoma	9.5%
189	Anaplastic Oligodendroglioma	9.5%
190	Bone neoplasms	9.3%
191	Leukoplakia	9.3%
192	Lymphocele	9.3%
193	Pancreatic Cyst	9.3%
194	Skin Neoplasms	9.3%
195	Hematologic Neoplasms	9.3%
196	Barrett Esophagus	9.2%
197	Breast Cyst	9.2%
198	Actinic keratosis	9.2%
199	Mediastinal Cyst	9.2%
200	Neoplasm Invasiveness	9.2%
201	Neoplasm Metastasis	9.2%
202	Neoplasm Recurrence, Local	9.2%
203	Parovarian Cyst	9.2%
204	Pericardial Cyst	9.2%
205	Splenic Neoplasms	9.2%
206	Thymic Cyst	9.2%
207	Carcinogenesis	9.2%
208	Myxoid cyst	9.2%
209	Metastasis	9.2%
210	Adenomatous Polyposis Coli	8.9%
211	Waldenstrom Macroglobulinemia	8.7%
212	Multiple Myeloma	8.7%
213	Multiple Endocrine Neoplasia Type 1	8.5%
214	fibroma	8.4%
215	Fibromatosis	8.4%
216	Osteoblastoma	8.4%
217	Osteoma	8.4%
218	Rhabdomyoma	8.4%
219	Chondromatosis	8.4%
220	Hemangioblastoma	8.4%
221	Lymphoma, Extranodal NK-T-Cell	8.4%
222	insulinoma	8.3%
223	Nasopharyngeal carcinoma	8.3%
224	Mastocytosis	8.2%
225	Sturge-Weber Syndrome	8.2%
226	Gastrointestinal Stromal Tumors	8.1%
227	Hemangioma, Cavernous	8.1%
228	Leukemia, T-Cell	8%
229	Leukemia, B-Cell	8%
230	Adrenocortical carcinoma	8%
231	Lymphoma, Follicular	8%
232	T-Cell Lymphoma	8%
233	Mantle cell lymphoma	8%
234	Glioblastoma	7.9%
235	Glioblastoma Multiforme	7.9%
236	Liver Neoplasms, Experimental	7.8%
237	Corpus Luteum Cyst	7.6%
238	Ovarian Cysts	7.6%
239	Parathyroid Neoplasms	7.6%
240	Peritoneal Neoplasms	7.6%
241	Thyroid Neoplasm	7.6%
242	Thyroid carcinoma	7.6%
243	Gastrinoma	7.2%
244	Glucagonoma	7.2%
245	granulosa cell tumor	7.1%
246	Renal Cell Carcinoma	7.1%
247	Papillary Renal Cell Carcinoma	7.1%
248	Carcinoma, Endometrioid	6.8%
249	Mastocytoma	6.8%
250	Pancreatic Neoplasm	6.7%
251	Mastocytosis, Systemic	6.7%
252	Leukemia, Myeloid, Chronic-Phase	6.7%
253	Choledochal Cyst	6.7%
254	Fibromatosis, Aggressive	6.6%
255	Fibromatosis, Abdominal	6.6%
256	Peutz-Jeghers Syndrome	6.5%
257	Retroperitoneal Neoplasms	6.5%
258	Tracheal Neoplasms	6.2%
259	Leukoplakia, Oral	6%
260	Paraneoplastic Cerebellar Degeneration	6%
261	Optic Nerve Glioma	6%
262	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	5.6%
263	Leukemia, Large Granular Lymphocytic	5.6%
264	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	5.6%
265	Lymphoma, T-Cell, Cutaneous	5.6%
266	Lymphoma, AIDS-Related	5.6%
267	Enteropathy-Associated T-Cell Lymphoma	5.6%
268	Primary Effusion Lymphoma	5.6%
269	Denys-Drash Syndrome	5.5%
270	Leydig Cell Tumor	5.3%
271	Esophageal Neoplasms	5.3%
272	Mouth Neoplasms	5.3%
273	Central Nervous System Neoplasms	5.3%
274	Vascular Neoplasms	5.3%
275	Limbic Encephalitis	5.3%
276	Thymus Neoplasms	5.3%
277	Genital Neoplasms, Female	5.2%
278	Pancreatic Pseudocyst	5.2%
279	Lymphatic Metastasis	5.2%
280	Neoplasms, Unknown Primary	5.2%
281	Leukemic Infiltration	5.2%
282	Breast Neoplasms, Male	5.2%
283	Neoplasm Micrometastasis	5.2%
284	Triple Negative Breast Neoplasms	5.2%
285	Lambert-Eaton Myasthenic Syndrome	4.8%
286	Testicular Neoplasms	4.8%
287	Thyroid Nodule	4.6%
288	Dupuytren Contracture	4.5%
289	Adrenal Gland Neoplasms	4.4%
290	Gastrointestinal Neoplasms	4.4%
291	Genital Neoplasms, Male	4.4%
292	Liver neoplasms	4.4%
293	Uveal Neoplasms	4.4%
294	Urticaria Pigmentosa	4.4%
295	Urologic Neoplasms	4.4%
296	Mycosis Fungoides	4.4%
297	Lymphomatoid Papulosis	4.4%
298	Plasmablastic lymphoma	4.4%
299	Sebaceous Gland Neoplasms	4.3%
300	Spinal Neoplasms	4.3%
301	Bone Marrow Neoplasms	4.3%
302	Polycystic Ovary Syndrome	4.3%
303	Opsoclonus-Myoclonus Syndrome	4.3%
304	Xeroderma Pigmentosum	4.2%
305	Burkitt Lymphoma	4.2%
306	Myelitis, Transverse	3.8%
307	Nose Neoplasms	3.3%
308	Sezary Syndrome	3.3%
309	ovarian neoplasm	3.3%
310	Meningeal Neoplasms	3.2%
311	Pituitary Adenoma	3.1%
312	Pituitary Neoplasms	3.1%
313	Palatal Neoplasms	3.1%
314	Ear Neoplasms	2.8%
315	Eyelid Neoplasms	2.8%
316	Lung Neoplasms	2.8%
317	Pleural Neoplasms	2.8%
318	Cell Transformation, Viral	2.7%
319	Brain Neoplasms	2.7%
320	Salivary Gland Neoplasms	2.7%
321	Spinal Cord Neoplasms	2.7%
322	Tongue Neoplasms	2.7%
323	Uterine Neoplasms	2.7%
324	Vaginal Neoplasms	2.7%
325	Vulvar Neoplasms	2.7%
326	Uterine Cancer	2.7%
327	Fallopian Tube Neoplasms	2.7%
328	Zollinger-Ellison syndrome	2.6%
329	Pharyngeal Neoplasms	2.4%
330	Central Nervous System Cysts	2.3%
331	Bile Duct Neoplasms	2.3%
332	gallbladder neoplasm	2.3%
333	Intestinal Neoplasms	2.3%
334	Penile Neoplasms	2.3%
335	Prostatic Neoplasms	2.3%
336	Stomach Neoplasms	2.3%
337	Polycythemia Vera	2.3%
338	Meningeal Carcinomatosis	2.2%
339	Laryngeal neoplasm	2.1%
340	Bladder Neoplasm	2%
341	Kidney Neoplasm	2%
342	Ureteral Neoplasms	2%
343	Urethral Neoplasms	2%
344	Bronchial Neoplasms	1.9%
345	Multiple Pulmonary Nodules	1.9%
346	Supratentorial Neoplasms	1.9%
347	Endometrial Neoplasms	1.9%
348	Hypopharyngeal Neoplasms	1.6%
349	Pleural Effusion, Malignant	1.6%
350	Hypopharyngeal Cancer	1.6%
351	Parotid Neoplasms	1.6%
352	Prostatic Neoplasms, Castration-Resistant	1.6%
353	Nelson Syndrome	1.6%
354	Brain Stem Neoplasms	1.5%
355	Cecal Neoplasms	1.4%
356	Duodenal Neoplasms	1.4%
357	Nasopharyngeal Neoplasms	1.3%
358	Tonsillar Neoplasms	1.3%
359	Choroid Plexus Papilloma	1.3%
360	Cerebellar Neoplasms	1.3%
361	Colorectal Neoplasms	1.2%
362	Paranasal Sinus Neoplasms	1.1%
363	Radicular Cyst	1.1%
364	Appendiceal Neoplasms	1.1%
365	Colonic Neoplasms	1.1%
366	Rectal Neoplasms	1.1%
367	Maxillary Sinus Neoplasms	0.9%
368	Anus Neoplasms	0.8%
369	Sigmoid Neoplasms	0.8%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234